Recessively inherited L-DOPA-responsive parkinsonism in infancy caused by a point mutation (L205P) in the tyrosine hydroxylase gene
- PMID: 8817341
- DOI: 10.1093/hmg/5.7.1023
Recessively inherited L-DOPA-responsive parkinsonism in infancy caused by a point mutation (L205P) in the tyrosine hydroxylase gene
Abstract
Tyrosine hydroxylase (TH) catalyzes the conversion of L-tyrosine to L-dihydroxyphenylalanine (L-DOPA), the rate-limiting step in the biosynthesis of dopamine. This report describes a missense point mutation in the human TH (hTH) gene in a girl presenting parkinsonian symptoms in early infancy and a very low level of the dopamine metabolite homovanillic acid in the CSF. DNA sequencing revealed a T614-to-C transition in exon 5 (L205P). Both parents and the patient's brother are heterozygous for the mutation. Site-directed mutagenesis and expression in different systems revealed that the recombinant mutant enzyme had a low homospecific activity, i.e. approximately 1.5% of wt-hTH in E. coli and approximately 16% in a cell-free in vitro transcription-translation system. When transiently expressed in human embryonic kidney (A293) cells a very low specific activity (approximately 0.3% of wt-hTH) and immunoreactive hTH (< 2%) was obtained. The expression studies are compatible with the severe clinical phenotype of the L205P homozygous patient carrying this recessively inherited mutation. Treatment with L-DOPA resulted in normalisation of the CSF homovanillic acid concentration and a sustained improvement in parkinsonian symptoms.
Similar articles
-
Recessively inherited L-DOPA-responsive dystonia caused by a point mutation (Q381K) in the tyrosine hydroxylase gene.Hum Mol Genet. 1995 Jul;4(7):1209-12. doi: 10.1093/hmg/4.7.1209. Hum Mol Genet. 1995. PMID: 8528210
-
[Expression and assessment of double genes of tyrosine hydroxylase gene and aromatic L-amino acid decarboxylase gene in vitro].Sheng Li Xue Bao. 2003 Oct 25;55(5):583-8. Sheng Li Xue Bao. 2003. PMID: 14566408 Chinese.
-
Biochemical and molecular genetic characteristics of the severe form of tyrosine hydroxylase deficiency.Clin Chem. 1999 Dec;45(12):2073-8. Clin Chem. 1999. PMID: 10585338
-
Molecular genetics of dopa-responsive dystonia.Biol Chem. 1999 Dec;380(12):1355-64. doi: 10.1515/BC.1999.175. Biol Chem. 1999. PMID: 10661862 Review.
-
Molecular genetics of tyrosine 3-monooxygenase and inherited diseases.Biochem Biophys Res Commun. 2005 Dec 9;338(1):267-70. doi: 10.1016/j.bbrc.2005.07.186. Epub 2005 Aug 10. Biochem Biophys Res Commun. 2005. PMID: 16105653 Review.
Cited by
-
Nonmotor Symptoms in Dopa-Responsive Dystonia.Mov Disord Clin Pract. 2015 Jul 22;2(4):347-356. doi: 10.1002/mdc3.12211. eCollection 2015 Dec. Mov Disord Clin Pract. 2015. PMID: 30363518 Free PMC article. Review.
-
Mutational and biochemical analysis of dopamine in dystonia: evidence for decreased dopamine D2 receptor inhibition.Mol Neurobiol. 1998 Apr;16(2):135-47. doi: 10.1007/BF02740641. Mol Neurobiol. 1998. PMID: 9588625 Review.
-
Convergent mechanisms in etiologically-diverse dystonias.Expert Opin Ther Targets. 2011 Dec;15(12):1387-403. doi: 10.1517/14728222.2011.641533. Epub 2011 Dec 3. Expert Opin Ther Targets. 2011. PMID: 22136648 Free PMC article. Review.
-
A murine model for human sepiapterin-reductase deficiency.Am J Hum Genet. 2006 Apr;78(4):575-87. doi: 10.1086/501372. Epub 2006 Jan 31. Am J Hum Genet. 2006. PMID: 16532389 Free PMC article.
-
Evidence for specific phases in the development of human neuromelanin.J Neural Transm (Vienna). 2006 Jun;113(6):721-8. doi: 10.1007/s00702-006-0449-y. Epub 2006 Apr 11. J Neural Transm (Vienna). 2006. PMID: 16604299
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases